Table 1 Demographics and clinical characteristics of study in the training and validation cohorts

N

487

413

74

Age

  < 65

322 (66.12%)

209 (50.61%)

34 (45.95%)

  >  = 65

165 (33.88%)

204 (49.39%)

40 (54.05%)

Sex

 Male

322 (66.12%)

268 (64.89%)

54 (72.97%)

 Female

165 (33.88%)

145 (35.11%)

20 (27.03%)

Hypertension

 No

119 (24.44%)

113 (27.36%)

6 (8.11%)

 Yes

368 (75.56%)

300 (72.64%)

68 (91.89%)

Diabetes

 No

429 (88.09%)

364 (88.14%)

65 (87.84%)

 Yes

58 (11.91%)

49 (11.86%)

9 (12.16%)

Smoking

 No

375 (77.00%)

312 (75.54%)

63 (85.14%)

 Yes

112 (23.00%)

101 (24.46%)

11 (14.86%)

Drinking

 No

359 (73.72%)

295 (71.43%)

64 (86.49%)

 Yes

128 (26.28%)

118 (28.57%)

10 (13.51%)

Hematoma volume

  < 20

383 (78.64%)

322 (77.97%)

61 (82.43%)

 20–40

55 (11.29%)

45 (10.90%)

10 (13.51%)

  >  = 40

49 (10.06%)

46 (11.14%)

3 (4.05%)

Intraventricular hemorrhage

 No

355 (72.90%)

299 (72.40%)

56 (75.68%)

 Yes

132 (27.10%)

114 (27.60%)

18 (24.32%)

Infratentorial hemorrhage

 No

431 (88.50%)

375 (90.80%)

56 (75.68%)

 Yes

56 (11.50%)

38 (9.20%)

18 (24.32%)

Outcome

 Good outcome

281 (57.70%)

233 (56.42%)

48 (64.86%)

 Poor outcome

206 (42.30%)

180 (43.58%)

26 (35.14%)

White blood cell

8.65 ± 3.80

8.69 ± 3.93

8.42 ± 2.98

Neutrophils

6.86 ± 4.87

6.72 ± 3.77

7.62 ± 8.79

Lymphocyte

1.39 ± 0.69

1.41 ± 0.69

1.33 ± 0.69

Urine nitrogen

5.73 ± 2.69

5.76 ± 2.74

5.59 ± 2.46

Creatinine

79.93 ± 54.24

80.70 ± 54.16

75.61 ± 54.85

Uric acid

338.18 ± 124.69

351.04 ± 123.55

266.43 ± 105.84

ALT

21.72 ± 11.64

21.37 ± 11.32

23.71 ± 13.22

AST

27.32 ± 14.04

26.42 ± 12.17

32.31 ± 21.13

Glucose

6.70 ± 2.45

6.69 ± 2.49

6.73 ± 2.20

Systolic pressure

162.71 ± 26.85

163.69 ± 27.29

157.23 ± 23.68

Diastolic pressure

93.31 ± 17.30

93.90 ± 17.30

89.99 ± 17.04

GCS scores

12.99 ± 3.38

12.86 ± 3.42

13.70 ± 3.08

NIHSS scores

9.70 ± 9.59

10.08 ± 9.73

7.59 ± 8.56